Dr. Gutterman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1971 - 1972
- Duke University HospitalResidency, Internal Medicine, 1965 - 1969
- Duke University HospitalInternship, Transitional Year, 1964 - 1965
- Virginia Commonwealth University School of MedicineClass of 1964
Certifications & Licensure
- TX State Medical License 1971 - 2017
Publications & Presentations
PubMed
- 326 citationsInterferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous Leukemia: Philadelphia Chromosome-Positive PatientsMoshe Talpaz, Hagop M. Kantarjian, Razelle Kurzrock, Jose M. Trujillo, Jordan U. Gutterman
Annals of Internal Medicine. 1991-04-01 - 517 citationsHematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaA in Chronic Myelogenous LeukemiaMoshe Talpaz, Hagop M. Kantarjian, Kenneth B. McCredie, Jose M. Trujillo, Michael J. Keating
The New England Journal of Medicine. 1986-04-24 - 49 citationsTherapy of chronic myelogenous leukemia: chemotherapy and interferons.Moshe Talpaz, Hagop M. Kantarjian, Razelle Kurzrock, Jordan U. Gutterman
Seminars in Hematology. 1988-01-01
Press Mentions
- John A. Clements Dies at 101; His Research Saved Thousands of BabiesSeptember 19th, 2024
- Pioneering Cancer Researcher Emil Freireich Dies at 93February 5th, 2021
- Skin Patches for More Medicines? Some Large Molecules Sneak Through Skin on Their OwnDecember 12th, 2012
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: